TP53 and cancer: Given the prevalence of nitrosative stress in the tumor microenvironment of various cancers, including colorectal and breast malignancies, our results offer a conceptual framework for investigating S-nitrosylated p53 and related redox-sensitive proteins as candidate biomarkers and therapeutic targets in inflammation-associated cancers.